Private Placement

By replacing $200 million in preferred stock with subordinated notes, the cooperative sidesteps a major rate reset to protect its rural borrowers.

PBF Energy is replacing pricey 7.875% debt with $500M in 0% exchangeable notes. We decode the savvy financial engineering and its strategic implications.

With its inaugural fund oversubscribed and 70% deployed, Bear Creek Fund Advisors proves its model for finding value in essential housing and healthcare assets.

As travel tech giant Sabre leans into its AI future, it's overhauling its finances with a massive $1.1 billion debt offering. Here's the inside story.

The legal finance leader is optimizing its balance sheet via a private placement, showcasing the power of private credit for niche, high-growth industries.

Forward Water Technologies secured $535k in high-interest debt, a risky but vital move. We analyze if this costly capital can propel its green tech to market.

Redwood Trust announced a sophisticated capital raise to refinance debt and fuel growth, but investors reacted with fear, sending shares down 22%. Why?

USA Compression Partners is refinancing debt with a $600M private note offering. We explore the strategy behind the deal and what it reveals about trust.

A tiny $150k financing reveals a masterclass in leveraging national policy, tax incentives, and geological promise in Canada's resource sector.

As Vertical Aerospace courts investors, its hybrid and defense pivots will be tested. Can it secure the capital needed to clear the runway to certification?

Hercules Capital just secured $2.3B, cementing its dominance in venture debt. What does this massive capital infusion mean for the future of tech startups?

With a massive cash infusion and novel brain-delivery tech, newly public Korsana Biosciences is betting it can succeed where many have failed in neurodegeneration.

Michelin's new global share plan offers a steep 30% discount to 114,000 staff. Is this a savvy play for retention or a dilution risk for investors?

Intellia Therapeutics secures a massive non-dilutive debt facility from OrbiMed, a strategic move to fund its one-time CRISPR therapy for HAE.

A new 347 MW solar farm breaks ground near Houston, but the real story is the strategic international alliance and corporate demand fueling Texas's future.

Argo Corp. reports a stunning 680% revenue jump as its Smart Routing™ tech gains traction, securing new municipal contracts and a $10M investment.

Inflection Point’s latest SPAC closes a major IPO, but it’s not 2021. This is a story of seasoned players, mixed track records, and a hunt for real disruption.

A strategic merger combines Chemomab's promising drug, nebokitug, with Scipher's AI platform, aiming to de-risk development and transform RA treatment.

Struggling battery firm Expion Energy makes a shocking pivot to oil and gas. The reason? The massive, unrelenting energy appetite of AI data centers in Louisiana.

The electronics repair chain is rapidly expanding, but its repeated struggle to close a $2.5M financing round signals a deeper story about its financial health.